Although inhibition of BRD4 suppresses cardiac hypertrophy and pathologic cardiac remodeling [17, 18], cardiomyocyte-specific deletion of BRD4 in mice triggers progressive deterioration of cardiac contractile function and eventually lead to dilated cardiomyopathy [19]. Here, BRD4 is linked to cardiac hypertrophy.